methyl 4-(3'-ethyl-6-fluorobiphenyl-2-yl)-4-hydroxy-4-((3R)-1-(3-hydroxy-4-(methylamino)butanoyl)piperidin-3-yl)butylcarbamate

ID: ALA4212859

Chembl Id: CHEMBL4212859

PubChem CID: 59620461

Max Phase: Preclinical

Molecular Formula: C30H42FN3O5

Molecular Weight: 543.68

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCc1cccc(-c2c(F)cccc2C(O)(CCCNC(=O)OC)[C@@H]2CCCN(C(=O)CC(O)CNC)C2)c1

Standard InChI:  InChI=1S/C30H42FN3O5/c1-4-21-9-5-10-22(17-21)28-25(12-6-13-26(28)31)30(38,14-8-15-33-29(37)39-3)23-11-7-16-34(20-23)27(36)18-24(35)19-32-2/h5-6,9-10,12-13,17,23-24,32,35,38H,4,7-8,11,14-16,18-20H2,1-3H3,(H,33,37)/t23-,24?,30?/m1/s1

Standard InChI Key:  FWSYQZYECHPKKP-QFYHAUMRSA-N

Associated Targets(Human)

REN Tclin Renin (5251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 543.68Molecular Weight (Monoisotopic): 543.3108AlogP: 3.59#Rotatable Bonds: 12
Polar Surface Area: 111.13Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.80CX Basic pKa: 9.75CX LogP: 3.03CX LogD: 0.73
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -0.52

References

1. Lawhorn BG, Tran T, Hong VS, Morgan LA, Le BT, Harpel MR, Jolivette L, Diaz E, Schwartz B, Gross JW, Tomaszek T, Semus S, Concha N, Smallwood A, Holt DA, Kallander LS..  (2017)  Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition.,  27  (21): [PMID:28985999] [10.1016/j.bmcl.2017.09.046]

Source